Close

Nu Skin Enterprises Increases Stock Repurchase Authorization

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

From AI-powered EHRs to Real-Time Data...

Indonesia becomes the first country in the world to...

Beyond the Bedside: How Remote IT...

As American hospitals continue to grapple with an increasing...

MEDICAL FAIR THAILAND 2025 opens next...

MEDICAL FAIR THAILAND 2025, the 11th edition of Thailand’s...

Siemens, Prisma Health Value Partnership Boost...

Based in Greenville, USA, Siemens Healthineers, Prisma Health are...
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that its board of directors has increased its stock repurchase authorization to $500 million, an increase of approximately $260 million. 
"We remain confident in our ability to grow the business as we begin to introduce our innovative new ageLOC products," said Ritch Wood, chief financial officer. "We plan to use our financial strength to repurchase shares and create shareholder value."

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back